Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
May 19, 2022
Document Date
May 17, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/
Filer
HUMPHREY JEFFREY